Old Web
English
Sign In
Acemap
>
Paper
>
372 Preclinical Characterization of RG7256, a Potent and Selective BRAF Inhibitor with Differentiation From Vemurafenib
372 Preclinical Characterization of RG7256, a Potent and Selective BRAF Inhibitor with Differentiation From Vemurafenib
2012
Fei Su
L. Xu
B. Higgings
Hong Yang
Kathryn Packman
Holly Hilton
Kathleen Schostack
G Bollag
J. Tsai
G. Habets
Keywords:
Vemurafenib
Immunology
BRAF inhibitor
Cancer research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]